Viewing Study NCT02271906


Ignite Creation Date: 2025-12-26 @ 10:59 AM
Ignite Modification Date: 2026-03-01 @ 1:48 AM
Study NCT ID: NCT02271906
Status: TERMINATED
Last Update Posted: 2019-04-30
First Post: 2014-10-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung Cancer View
None Non small cell lung cancer View
None NSCLC View
None Adenocarcinoma View
None Squamous cell carcinoma View
None BIBW 2992 View
None Afatinib View